Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?

Nature Clinical Practice Nephrology volume 2, pages 248–249 (2006)Cite this article

boxed-textMoe SM et al. (2005) Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20: 2186–2193

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rodriguez M et al. (2005) The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 288: F253–F264

    Article  CAS  Google Scholar 

  2. Block GA et al. (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 1516–1525

    Article  CAS  Google Scholar 

  3. Moe SM et al. (2005) Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67: 760–771

    Article  CAS  Google Scholar 

  4. Cunningham J et al. (2005) Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 68: 1793–1800

    Article  CAS  Google Scholar 

  5. Colloton M et al. (2005) Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney Int 67: 467–476

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Division of Nephrology and Dialysis Center, Kobe University School of Medicine, Kobe, Japan

    Masafumi Fukagawa

Authors
  1. Masafumi Fukagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masafumi Fukagawa.

Ethics declarations

Competing interests

The author is a scientific advisor for Kirin Brewery Co. Ltd., Japan, and has received a research grant unrelated to cinacalcet from this company.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukagawa, M. Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?. Nat Rev Nephrol 2, 248–249 (2006). https://doi.org/10.1038/ncpneph0154

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0154

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing